MedTrace Logo

CCSV - Post Market Clinical Follow-up Study

NCT06836908 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2025-02-20

No results posted yet for this study

Summary

The main goal of this observational study is the evaluation of Chest Compression Synchronized Ventilation (CCSV) regarding oxygenation in terms of PaO2 assessed by routine blood gas analysis, hemodynamic effects, 30-day outcome and safety in comparison to Intermittent Positive Pressure Ventilation (IPPV) as data in humans is sparse especially in direct comparison to other ventilation modes.

Cardiac arrest patients in Vienna, Austria will be preclinically randomized (IPPV and CCSV) and ventilated accordingly during CPR. Differences in oxygenation, decarboxylation, systemic perfusion and cerebral oxygenation, the patient's 30-day outcome as well as ventilator-associated adverse events (e.g., pneumothorax) will be recorded and analyzed.

Conditions

  • Cardiac Arrest

Sponsors & Collaborators

  • WEINMANN Emergency, Medical Technology GmbH & Co. KG

    collaborator UNKNOWN

  • Berufsrettung Wien

    collaborator UNKNOWN

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Sebastian Schnaubelt, MD, PhD · Department of Emergency Medicine, Medical University of Vienna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2026-06-30
Completion
2026-09-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06836908 on ClinicalTrials.gov